Biomarin Pharmaceutical (BMRN) Land & Improvements (2010 - 2013)

Biomarin Pharmaceutical has disclosed Land & Improvements across 4 years of filings, most recently posting $11.6 million for Q4 2013.

• Quarterly Land & Improvements changed 0.0% year-over-year to $11.6 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $11.6 million (changed 0.0% YoY) and the FY2013 annual result came in at $11.6 million, changed 0.0% from the prior year.
• Land & Improvements steadied at $11.6 million in Q4 2013, from $11.6 million in the prior quarter.
• Over five years, Land & Improvements peaked at $51.1 million in Q2 2012 and troughed at $10.1 million in Q3 2012.
• A 4-year average of $25.4 million and a median of $11.6 million in 2012 frame the typical range for Land & Improvements.
• Annual changes were most pronounced in 2011 — Land & Improvements grew 28.99% — and 2013, when it plunged 77.29%.
• Tracing BMRN's Land & Improvements over 4 years: stood at $37.7 million in 2010, then rose by 28.99% to $48.6 million in 2011, then plunged by 76.1% to $11.6 million in 2012, then changed by 0.0% to $11.6 million in 2013.
• Business Quant data shows BMRN's Land & Improvements at $11.6 million in Q4 2013, $11.6 million in Q3 2013, and $11.6 million in Q2 2013.